JN-101

N/A

Report date: 2025/12/26 15:27:43
NME

Base Information

Drug NameJN-101
Drug Alias NameJN-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionMicroRNAs inhibitors
TargetsMicroRNAs
Therapy Area/IndicationsMyocardial InfarctionMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesJAAN Biotherapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesJAAN Biotherapeutics LLC
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A